Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer

Publication date: Available online 26 May 2020Source: Gynecologic Oncology ReportsAuthor(s): John K. Chan, David S. Lakomy, Yassmina McDonald, Daniel S Kapp
Source: Gynecologic Oncology Reports - Category: OBGYN Source Type: research